The articles collectively highlight an ongoing investigation into ActBlue, a prominent Democratic fundraising platform, led by CEO Regina Wallace-Jones. The inquiry focuses on allegations that ActBlue misled Congress regarding its practices for vetting overseas donations, which are prohibited in U.S. elections. The narrative intensifies as Wallace-Jones plans to invoke her Fifth Amendment rights during her testimony, raising questions about potential legal implications and the integrity of the organization's operations. The political context surrounding these allegations suggests a deeper partisan struggle, as ActBlue is a key player in Democratic fundraising efforts.
Regina Wallace-Jones, CEO of ActBlue, will testify before the House Administration Committee on June 10, 2026, amid an investigation into alleged donor fraud. The committee is examining whether ActBlue misled Congress about its practices for vetting overseas donations, with representatives of the group denying the allegations and claiming political motivation behind the probe.
Regina Wallace-Jones, CEO of ActBlue, will testify before the House Administration Committee regarding allegations of misleading Congress about donor fraud. The investigation focuses on ActBlue's practices for vetting overseas donations, which are generally prohibited in U.S. elections. The committee has expanded its inquiry to include interviews with board members and requested documents related to the organization's internal practices.
Regina Wallace-Jones, CEO of ActBlue, plans to invoke the Fifth Amendment in her upcoming testimony to Congress. This decision is part of her participation in the 2024 Democratic National Convention in Chicago.
Regina O'Brien, CEO of ActBlue, invoked her Fifth Amendment rights during a Congressional hearing concerning allegations of illegal foreign donations to federal campaigns. She declined to answer questions based on legal counsel's advice.
Regina Wallace-Jones, CEO of ActBlue, invoked her Fifth Amendment rights during a congressional hearing regarding allegations of foreign donations to the Democratic donation platform. Lawmakers questioned her about previous statements on the platform's fraud-prevention practices, which internal memos later suggested could be misleading.